NeoPharm CO., LTD. (KOSDAQ:092730)
South Korea · Delayed Price · Currency is KRW 19,450
-250 (-1.27%)
At close: Dec 5, 2025
NeoPharm CO., LTD. Revenue
NeoPharm CO., LTD. had revenue of 32.20B KRW in the quarter ending September 30, 2025, with 23.12% growth. This brings the company's revenue in the last twelve months to 129.81B, up 15.70% year-over-year. In the year 2024, NeoPharm CO., LTD. had annual revenue of 119.01B with 22.56% growth.
Revenue (ttm)
129.81B
Revenue Growth
+15.70%
P/S Ratio
2.34
Revenue / Employee
729.29M
Employees
184
Market Cap
304.22B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 119.01B | 21.91B | 22.56% |
| Dec 31, 2023 | 97.10B | 12.07B | 14.20% |
| Dec 31, 2022 | 85.03B | -2.90B | -3.30% |
| Dec 31, 2021 | 87.93B | 6.31B | 7.72% |
| Dec 31, 2020 | 81.63B | -1.61B | -1.94% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| CJ Cheiljedang | 29.38T |
| E-MART | 28.91T |
| LG H&H | 6.49T |
| KT&G Corporation | 6.42T |
| AMOREPACIFIC Holdings | 4.55T |
| Amorepacific | 4.18T |
| Nongshim | 3.49T |
| ORION | 3.27T |